Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Atrial fibrillation: stroke prevention in older adults.

Quinn GR, Fang MC.

Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003. Review.

PMID:
23101573
[PubMed - indexed for MEDLINE]
2.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
[PubMed - indexed for MEDLINE]
3.

Antithrombotic therapies for stroke prevention in atrial fibrillation.

Economides Muñoz C, Singh BN.

Minerva Cardioangiol. 2004 Apr;52(2):125-39. Review.

PMID:
15194994
[PubMed - indexed for MEDLINE]
Free Article
4.

An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.

Deedwania P, Huang GW.

Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review.

PMID:
23160166
[PubMed - indexed for MEDLINE]
5.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
[PubMed - indexed for MEDLINE]
6.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
[PubMed - indexed for MEDLINE]
7.

Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.

Fitzgerald BT, Cohn SL, Klein AL.

Cleve Clin J Med. 2005 Apr;72 Suppl 1:S24-30. Review.

PMID:
15853176
[PubMed - indexed for MEDLINE]
Free Article
8.

Anticoagulants in patients with atrial fibrillation and end-stage renal disease.

Brimble KS, Ingram AJ, Eikelboom JW, Hart RG.

Postgrad Med. 2012 Nov;124(6):17-25. doi: 10.3810/pgm.2012.11.2609. Review.

PMID:
23322135
[PubMed - indexed for MEDLINE]
9.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
[PubMed - indexed for MEDLINE]
10.

Anticoagulation strategies in atrial fibrillation.

Menezes AR, Artham S, Lavie CJ, Khatib S.

Rev Cardiovasc Med. 2012;13(1):e1-13. Review.

PMID:
22565533
[PubMed - indexed for MEDLINE]
11.

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ.

Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Review.

PMID:
18508982
[PubMed - indexed for MEDLINE]
12.

Optimising stroke prevention in non-valvular atrial fibrillation.

Ederhy S, Cohen A.

Expert Opin Pharmacother. 2006 Oct;7(15):2079-94. Review.

PMID:
17020434
[PubMed - indexed for MEDLINE]
13.

Incidental atrial fibrillation and its management.

Saliba W.

Postgrad Med. 2011 Mar;123(2):27-35. doi: 10.3810/pgm.2011.03.2260. Review.

PMID:
21474890
[PubMed - indexed for MEDLINE]
14.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
[PubMed - indexed for MEDLINE]
15.

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Hughes M, Lip GY; Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence.

Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508. Review.

PMID:
18278178
[PubMed - indexed for MEDLINE]
16.

Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.

Strong SH, Halperin JL.

Geriatrics. 2007 Mar;62(3):22-7. Review.

PMID:
17346095
[PubMed - indexed for MEDLINE]
17.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

PMID:
22246948
[PubMed - indexed for MEDLINE]
18.

Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.

Yates SW.

Hosp Pract (1995). 2011 Oct;39(4):7-16. doi: 10.3810/hp.2011.10.918. Review.

PMID:
22056819
[PubMed - indexed for MEDLINE]
19.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
[PubMed - indexed for MEDLINE]
20.

Optimization of anticoagulation with warfarin for stroke prevention: pharmacogenetic considerations.

Tomek A, Matoska V, Eisert C, Serebruany VL.

Am J Ther. 2011 May;18(3):e55-66. doi: 10.1097/MJT.0b013e3181cea0cd. Review.

PMID:
20335792
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk